The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer.
Oncotarget
; 6(32): 33602-11, 2015 Oct 20.
Article
in En
| MEDLINE
| ID: mdl-26418897
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinazolines
/
Carcinoma, Non-Small-Cell Lung
/
Receptor, ErbB-3
/
Neuregulin-1
/
Protein Kinase Inhibitors
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Oncotarget
Year:
2015
Document type:
Article
Affiliation country:
Japón
Country of publication:
Estados Unidos